Protagenic Therapeutics, Inc.\new Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Protagenic Therapeutics, Inc.\new Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $11.3K, a 67.8% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$378K, a 943% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2023 was -$474K, a 20841% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2022 was $2.28K.
  • Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2021 was -$383K, a 13400% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$378K $11.3K -$23.8K -67.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$354K $60.8K +$127K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$481K $14.1K -$7.13K -33.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$474K -$464K -$518K -953% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
Q3 2023 $44.8K $35.1K +$36.3K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $8.51K -$65.8K -$35.8K -119% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $44.3K $21.2K +$42K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $2.28K $54.4K +$83.6K Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 -$81.3K -$1.25K +$113K +98.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$194K -$30K +$209K +87.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$403K -$20.8K -$20.6K -7852% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$383K -$29.2K -$42.4K -320% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$340K -$114K -$160K -349% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$180K -$239K -$161K -205% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$19.5K -$262 -$22.4K -101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $2.88K $13.2K +$25.9K Oct 1, 2020 Dec 31, 2020 10-K 2022-04-07
Q3 2020 -$23K $45.9K -$20.4K -30.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.59K -$78.4K -$305K -135% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $303K $22.1K -$32.6K -59.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $335K -$12.6K +$254K +95.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $81.7K $66.3K +$65.7K +11534% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $15.9K $227K +$213K +1555% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$197K $54.8K +$46.3K +543% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-18
Q4 2018 -$243K -$266K -$279K -2203% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-29
Q3 2018 $35.5K $570 -$71.9K -99.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $107K $13.7K -$6.8K -33.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $114K $8.53K +$8.46K +12624% Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-05-16
Q4 2017 $106K $12.7K +$12.5K +6261% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $93.2K $72.5K +$73.1K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $20.1K $20.5K +$48.3K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$28.2K $67.00 +$14.1K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$42.3K $199 +$8.2K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$50.5K -$649 +$78K +99.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$129K -$27.8K -$19.7K -241% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$109K -$14K -$26.2K -216% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$82.7K -$8K -$6K -300% Oct 1, 2015 Dec 31, 2015 10-Q 2016-03-11
Q3 2015 -$76.7K -$78.6K -$77.6K -7764% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 $974 -$8.16K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $12.1K -$4.87K -28.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-07-25
Q4 2014 -$2K -$12K -120% Oct 1, 2014 Dec 31, 2014 10-Q 2016-03-11
Q3 2014 -$1K -$5K -125% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q1 2014 $17K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $10K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 $4K Jul 12, 2013 Sep 30, 2013 10-Q 2014-11-13
Q3 2011 $550K +$470K +588% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$1.17M -$1.23M -2229% Apr 1, 2011 Jun 30, 2011 10-Q/A 2011-09-07
Q3 2010 $80K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $55K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.